- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: dabrafenib and trametinib
Total 271487 results
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Triple Negative Breast Cancer, NSCLC - AdenocarcinomaUnited States, France, Taiwan, Canada, Italy, Singapore, Belgium, Spain, Israel
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedMelanomaAustralia, France, Germany, United States, Italy
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
JS InnoPharm, LLCSuspended
-
University Hospital TuebingenTerminatedMetastatic Melanoma (Carrying BRAF V600 Mutation)Germany
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Recurrent Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
GlaxoSmithKlineWithdrawn
-
St. Justine's HospitalCHU de Quebec-Universite Laval; Montreal Children's Hospital of the MUHCActive, not recruitingLow-grade Glioma | Plexiform Neurofibroma | Central Nervous System GliomaCanada
-
GlaxoSmithKlineCompleted
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Geisinger ClinicNot yet recruitingPneumonia, Pneumococcal | Vaccine
-
Anna RaciborskaMaria Sklodowska-Curie National Research Institute of Oncology; Łukasiewicz... and other collaboratorsRecruiting
-
Shanghai Chest HospitalCompleted
-
Region SkaneNovartisActive, not recruitingChild | Neurofibromatosis 1 | Neurofibroma, PlexiformSweden
-
Centre Leon BerardNovartisCompletedColorectal Cancer | Metastatic Cancer | Advanced CancerFrance
-
Grupo Español Multidisciplinar de MelanomaGlaxoSmithKlineCompletedMalignant Melanoma Stage IV | Malignant Melanoma Stage IIIcSpain
-
GlaxoSmithKlineCompletedCancerUnited States, France, Germany, Belgium
-
American Regent, Inc.Not yet recruiting
-
Massachusetts General HospitalGlaxoSmithKlineCompletedPapillary Thyroid CarcinomaUnited States
-
Boehringer IngelheimActive, not recruitingSolid Tumors, KRAS Mutation; SOS1United States, Netherlands, Germany
-
Albany Research Institute, Inc.CompletedRosacea, ErythematotelangiectaticUnited States
-
University of California, San FranciscoNovartis Pharmaceuticals; American Cancer Society, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
Kartos Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Cancer | Oncology | Advanced Malignancy | Oncology PatientsUnited States
-
GlaxoSmithKlineCompletedMelanomaUnited States, Italy, United Kingdom, France, Sweden, Germany, Poland, Australia, Belgium, Austria, Canada, Czechia, Greece, Russian Federation, Ukraine, Norway, Switzerland, New Zealand, Argentina
-
GlaxoSmithKlineCompleted
-
Washington University School of MedicineNational Comprehensive Cancer NetworkCompletedMouth Neoplasms | Neoplasms, OralUnited States
-
GlaxoSmithKlineCompletedCancerUnited States, Australia, United Kingdom
-
Xynomic Pharmaceuticals, Inc.Not yet recruitingMelanoma | Cancer | Colorectal Cancer | Nonsmall Cell Lung Cancer | Thyroid Cancer | BRAF V600 Mutation
-
University Health Network, TorontoGlaxoSmithKlineCompletedAdenocarcinoma | Pancreatic CancerCanada
-
GlaxoSmithKlineCompletedNeoplasms | CancerUnited Kingdom, France
-
PfizerCompletedBreast Neoplasms | Metastatic Breast CancerUnited States
-
GlaxoSmithKlineWithdrawnCancer | Metastatic Uveal Melanoma | GNA11 Mutation-positive Metastatic Melanoma | GNAQ Mutation-positive Metastatic Melanoma
-
GlaxoSmithKlineCompleted
-
Novartis PharmaceuticalsTerminatedSolid Tumors for Phase Ib | Pancreatic Cancer for Phase II | Colorectal Cancer for Phase IIUnited States, Canada, Australia, Belgium, Germany, Netherlands, Spain
-
Sarcoma Alliance for Research through CollaborationNovartisWithdrawnGastrointestinal Stromal Tumors
-
GlaxoSmithKlineTerminated
-
M.D. Anderson Cancer CenterRecruitingThyroid Gland Anaplastic Carcinoma | Thyroid Gland Squamous Cell CarcinomaUnited States
-
St. Jude Children's Research HospitalNovartis PharmaceuticalsActive, not recruitingGlioma | Neoplasms | Glioblastoma | Neoplasms, Neuroepithelial | Central Nervous System Neoplasms | Brain Cancer | Brain Tumor | Ependymoma | Medulloblastoma | Anaplastic Astrocytoma | Anaplastic Ganglioglioma | Anaplastic Ependymoma | Anaplastic Oligodendroglioma | Pineoblastoma | Recurrent Medulloblastoma | CNS Tumor | Pediatric... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedAdvanced and Selected Solid TumorsBelgium, Spain, Canada, Switzerland, United States
-
GlaxoSmithKlinePfizerCompleted
-
GlaxoSmithKlineCompleted
-
Changhai HospitalCompleted
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Susan G. Komen Breast Cancer...CompletedBreast CancerUnited States